Truncated structural variants of lipoarabinomannan in Mycobacterium leprae and an ethambutol-resistant strain of Mycobacterium tuberculosis.
about
Reconstitution of functional mycobacterial arabinosyltransferase AftC proteoliposome and assessment of decaprenylphosphorylarabinose analogues as arabinofuranosyl donorsThe human macrophage mannose receptor directs Mycobacterium tuberculosis lipoarabinomannan-mediated phagosome biogenesisBiosynthesis of mycobacterial lipoarabinomannan: role of a branching mannosyltransferaseAnalysis of a new mannosyltransferase required for the synthesis of phosphatidylinositol mannosides and lipoarbinomannan reveals two lipomannan pools in corynebacterineaeLipoarabinomannan of Mycobacterium: mannose capping by a multifunctional terminal mannosyltransferaseGenetic basis for the synthesis of the immunomodulatory mannose caps of lipoarabinomannan in Mycobacterium tuberculosis.Sequencing of oligoarabinosyl units released from mycobacterial arabinogalactan by endogenous arabinanase: identification of distinctive and novel structural motifsThe identification and location of succinyl residues and the characterization of the interior arabinan region allow for a model of the complete primary structure of Mycobacterium tuberculosis mycolyl arabinogalactanControlled expression of branch-forming mannosyltransferase is critical for mycobacterial lipoarabinomannan biosynthesisMycobacterium tuberculosis cell wall released fragments by the action of the human lung mucosa modulate macrophages to control infection in an IL-10-dependent mannerHuman lung hydrolases delineate Mycobacterium tuberculosis-macrophage interactions and the capacity to control infection.The cell envelope glycoconjugates of Mycobacterium tuberculosisMycobacterium tuberculosis activates human macrophage peroxisome proliferator-activated receptor gamma linking mannose receptor recognition to regulation of immune responsesMutations in the essential arabinosyltransferase EmbC lead to alterations in Mycobacterium tuberculosis lipoarabinomannan.Analysis of antibody responses to Mycobacterium leprae phenolic glycolipid I, lipoarabinomannan, and recombinant proteins to define disease subtype-specific antigenic profiles in leprosy.Detailed structural and quantitative analysis reveals the spatial organization of the cell walls of in vivo grown Mycobacterium leprae and in vitro grown Mycobacterium tuberculosis.Structural differences in lipomannans from pathogenic and nonpathogenic mycobacteria that impact CD1b-restricted T cell responses.Isolation of a distinct Mycobacterium tuberculosis mannose-capped lipoarabinomannan isoform responsible for recognition by CD1b-restricted T cells.Polyphosphate kinases modulate Campylobacter jejuni outer membrane constituents and alter its capacity to invade and survive in intestinal epithelial cells in vitroChanges in the major cell envelope components of Mycobacterium tuberculosis during in vitro growth.Identification of Mycobacterium tuberculosis clinical isolates with altered phagocytosis by human macrophages due to a truncated lipoarabinomannan.Biosynthesis of D-arabinose in mycobacteria - a novel bacterial pathway with implications for antimycobacterial therapy.Inactivation of Mycobacterium tuberculosis mannosyltransferase pimB reduces the cell wall lipoarabinomannan and lipomannan content and increases the rate of bacterial-induced human macrophage cell death.Critical role of amino acid position 343 of surfactant protein-D in the selective binding of glycolipids from Mycobacterium tuberculosis.Methylthioxylose--a jewel in the mycobacterial crown?Deciphering the molecular bases of Mycobacterium tuberculosis binding to the lectin DC-SIGN reveals an underestimated complexity.Biosynthesis of the Methylthioxylose Capping Motif of Lipoarabinomannan in Mycobacterium tuberculosis.Characterization of the Antigenic Heterogeneity of Lipoarabinomannan, the Major Surface Glycolipid of Mycobacterium tuberculosis, and Complexity of Antibody Specificities toward This Antigen.Identification of serological biomarkers of infection, disease progression and treatment efficacy for leprosy
P2860
Q24614299-D7BA422B-9D87-439C-AE41-09D250E1234FQ24646191-09FEEF99-8D41-41EC-A535-213B8B6E37F6Q28486772-03058D67-C682-4285-9E26-42B08FDB00BEQ28487340-5C712551-675F-4C27-9F56-AC76F4727E94Q28487622-6C70F981-3FD1-4D52-A196-91F28471516BQ33243649-06CB21E0-0EE8-4C97-AD1E-3138BB67371BQ33266918-6AB09F02-BF91-4A76-8269-FD6363CEB8D6Q33321365-6AF48295-F039-4FB1-BD94-AAC249698E2DQ33809876-A9A85FE8-76D5-4C77-9A89-6AFFEA6A7034Q33822234-6652A4A6-A49D-49CD-B58B-3E5375ED101BQ34359480-8D0D9CB8-2B88-403C-B49C-DBDE340B3404Q34423962-515246B8-8D9D-44AC-95D1-4E5E9F6D0A84Q34459867-FDF912B4-67D5-48D2-AAE8-A3F4C4EE0AA1Q34737788-36AE2DB7-608B-4B92-BD50-50C6486727F3Q34738690-641034CE-04B7-467C-9D96-CE55E689BC08Q35067784-F522039C-F8D5-4ED3-BFE4-FF4CB8289670Q35371508-F0071750-A794-4100-B26C-E77ECDEECBA3Q36056056-09FD6E17-6F8A-40DC-A947-A5DD61A0EB4AQ36468668-43184BDC-A472-4EE8-8A8C-38BDCBE9427EQ36964224-2F619182-ABF6-480A-B5E9-C79BE5E8315BQ36968424-B97334F7-32EE-4196-8B13-614B7A35645CQ37142148-AF4CE2F5-7743-4A82-AFAC-522DCD73DD2DQ37207394-C4122BBD-9606-4B65-BA8D-CC939517B4ABQ37405394-690D78BB-B63E-4836-9483-20A4EABEAF9EQ38009185-AC2FF6FA-9B9B-4D58-8082-5D37A4F49195Q40679059-59B0B9F5-74CE-4967-A3DE-23971261C0B6Q46434051-21C53FAF-3EAC-4DE7-AD6E-49A3BA1CF737Q52334135-8650F2A9-EF99-46D1-9709-D216F70D21E9Q58852998-841A06C1-1A86-4243-851B-B1349DA81909
P2860
Truncated structural variants of lipoarabinomannan in Mycobacterium leprae and an ethambutol-resistant strain of Mycobacterium tuberculosis.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
2004年學術文章
@zh
2004年學術文章
@zh-hant
name
Truncated structural variants ...... of Mycobacterium tuberculosis.
@en
Truncated structural variants ...... of Mycobacterium tuberculosis.
@nl
type
label
Truncated structural variants ...... of Mycobacterium tuberculosis.
@en
Truncated structural variants ...... of Mycobacterium tuberculosis.
@nl
prefLabel
Truncated structural variants ...... of Mycobacterium tuberculosis.
@en
Truncated structural variants ...... of Mycobacterium tuberculosis.
@nl
P2093
P2860
P921
P356
P1476
Truncated structural variants ...... of Mycobacterium tuberculosis.
@en
P2093
Angela M Marques
Christopher D Rithner
Delphi Chatterjee
Jordi B Torrelles
Kay-Hooi Khoo
Nannan Zhang
Patrick J Brennan
Peter A Sieling
P2860
P304
41227-41239
P356
10.1074/JBC.M405180200
P407
P577
2004-07-19T00:00:00Z